Literature DB >> 8429255

Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency.

M G Traber1, R J Sokol, A Kohlschütter, T Yokota, D P Muller, R Dufour, H J Kayden.   

Abstract

We assessed whether patients with familial isolated vitamin E deficiency could discriminate between natural (RRR-) and synthetic (SRR-) stereoisomers of alpha-tocopherol labeled with six (d6) or three (d3) deuterium atoms, respectively. After oral administration of 20 mg of each of the stereoisomers, patients (seven) and controls (seven) had similar concentrations of both in chylomicrons, similar initial increases of both, and similar rates of decrease of d3-SRR-alpha-tocopherol in plasma. Patients and controls differed in their abilities to maintain plasma d6-RRR-alpha-tocopherol concentrations. Controls maintained plasma d6-RRR-alpha-tocopherol concentrations by preferentially secreting it in very low density lipoprotein (VLDL). Three of seven patients did not discriminate between the two stereoisomers and their plasma and lipoprotein d6-RRR-alpha-tocopherol concentrations declined rapidly. The remaining patients were intermediate between non-discriminators and controls in their ability to discriminate and maintain plasma d6-RRR-alpha-tocopherol concentrations. The degree of discrimination between the two stereoisomers in the patients was correlated with the age of onset of the neurologic disability (r2 = 0.64, P < 0.03). Estimates based on the rate of decrease of plasma d6-RRR-alpha-tocopherol in non-discriminators suggest that the entire plasma alpha-tocopherol pool of normal subjects is replaced daily. We suggest 1) that a hepatic alpha-tocopherol binding protein, which preferentially incorporates RRR-alpha-tocopherol into VLDL, is required to maintain plasma RRR-alpha-tocopherol concentrations; 2) that non-discriminators are lacking this protein, or have a marked defect in the RRR-alpha-tocopherol binding region of the protein; and 3) that patients who discriminate, but have difficulty maintaining plasma RRR-alpha-tocopherol concentrations, have a less severe defect, or perhaps a defect in the transfer function of the protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429255

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids.

Authors:  J Neuzil; P K Witting; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families.

Authors:  L Cavalier; K Ouahchi; H J Kayden; S Di Donato; L Reutenauer; J L Mandel; M Koenig
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 3.  Mechanisms for the prevention of vitamin E excess.

Authors:  Maret G Traber
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

Review 4.  Vitamins C and E: beneficial effects from a mechanistic perspective.

Authors:  Maret G Traber; Jan F Stevens
Journal:  Free Radic Biol Med       Date:  2011-05-25       Impact factor: 7.376

5.  Ataxia with vitamin E deficiency: refinement of genetic localization and analysis of linkage disequilibrium by using new markers in 14 families.

Authors:  N Doerflinger; C Linder; K Ouahchi; G Gyapay; J Weissenbach; D Le Paslier; P Rigault; S Belal; C Ben Hamida; F Hentati
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

6.  Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle.

Authors:  W Sattler; S Levak-Frank; H Radner; G M Kostner; R Zechner
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

7.  Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up.

Authors:  J Amiel; J C Maziere; I Beucler; M Koenig; L Reutenauer; N Loux; D Bonnefont; C Féo; P Landrieu
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

8.  Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior.

Authors:  K Aalto-Setälä; C L Bisgaier; A Ho; K A Kieft; M G Traber; H J Kayden; R Ramakrishnan; A Walsh; A D Essenburg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 9.  Recent advances in vitamin E metabolism and deficiency.

Authors:  Ephrem Eggermont
Journal:  Eur J Pediatr       Date:  2006-02-21       Impact factor: 3.183

10.  alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state.

Authors:  R Ricciarelli; A Tasinato; S Clément; N K Ozer; D Boscoboinik; A Azzi
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.